Technical Aspects and Development of Transcatheter Aortic Valve Implantation

Aortic stenosis is the most common valve disease requiring surgery or percutaneous treatment. Since the first-in-man implantation in 2002 we have witnessed incredible progress in transcatheter aortic valve implantation (TAVI). In this article, we review the technical aspects of TAVI development with...

Full description

Bibliographic Details
Main Authors: Klemen Steblovnik, Matjaz Bunc
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:https://www.mdpi.com/2308-3425/9/8/282
_version_ 1797444545049264128
author Klemen Steblovnik
Matjaz Bunc
author_facet Klemen Steblovnik
Matjaz Bunc
author_sort Klemen Steblovnik
collection DOAJ
description Aortic stenosis is the most common valve disease requiring surgery or percutaneous treatment. Since the first-in-man implantation in 2002 we have witnessed incredible progress in transcatheter aortic valve implantation (TAVI). In this article, we review the technical aspects of TAVI development with a look at the future. Durability, low thrombogenicity, good hydrodynamics, biocompatibility, low catheter profile, and deployment stability are the attributes of an ideal TAVI device. Two main design types exist—balloon-expandable and self-expanding prostheses. Balloon-expandable prostheses use a cobalt-chromium alloy frame providing high radial strength and radiopacity, while the self-expanding prostheses use a nickel-titanium (Nitinol) alloy frame, which expands to its original shape once unsheathed and heated to the body temperature. The valve is sewn onto the frame and consists of the porcine or bovine pericardium, which is specially treated to prevent calcinations and prolong durability. The lower part of the frame can be covered by polyethylene terephthalate fabric or a pericardial skirt, providing better sealing between the frame and aortic annulus. The main future challenges lie in achieving lower rates of paravalvular leaks and new pacemaker implantations following the procedure, lower delivery system profiles, more precise positioning, longer durability, and a good hemodynamic profile. Patient-specific design and the use of autologous tissue might solve these issues.
first_indexed 2024-03-09T13:13:08Z
format Article
id doaj.art-fc20832eea27477a8766cf6869dadc87
institution Directory Open Access Journal
issn 2308-3425
language English
last_indexed 2024-03-09T13:13:08Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Journal of Cardiovascular Development and Disease
spelling doaj.art-fc20832eea27477a8766cf6869dadc872023-11-30T21:40:07ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252022-08-019828210.3390/jcdd9080282Technical Aspects and Development of Transcatheter Aortic Valve ImplantationKlemen Steblovnik0Matjaz Bunc1Department of Cardiology, University Medical Centre Ljubljana, 1000 Ljubljana, SloveniaDepartment of Cardiology, University Medical Centre Ljubljana, 1000 Ljubljana, SloveniaAortic stenosis is the most common valve disease requiring surgery or percutaneous treatment. Since the first-in-man implantation in 2002 we have witnessed incredible progress in transcatheter aortic valve implantation (TAVI). In this article, we review the technical aspects of TAVI development with a look at the future. Durability, low thrombogenicity, good hydrodynamics, biocompatibility, low catheter profile, and deployment stability are the attributes of an ideal TAVI device. Two main design types exist—balloon-expandable and self-expanding prostheses. Balloon-expandable prostheses use a cobalt-chromium alloy frame providing high radial strength and radiopacity, while the self-expanding prostheses use a nickel-titanium (Nitinol) alloy frame, which expands to its original shape once unsheathed and heated to the body temperature. The valve is sewn onto the frame and consists of the porcine or bovine pericardium, which is specially treated to prevent calcinations and prolong durability. The lower part of the frame can be covered by polyethylene terephthalate fabric or a pericardial skirt, providing better sealing between the frame and aortic annulus. The main future challenges lie in achieving lower rates of paravalvular leaks and new pacemaker implantations following the procedure, lower delivery system profiles, more precise positioning, longer durability, and a good hemodynamic profile. Patient-specific design and the use of autologous tissue might solve these issues.https://www.mdpi.com/2308-3425/9/8/282aortic stenosisTAVImaterialstechnology
spellingShingle Klemen Steblovnik
Matjaz Bunc
Technical Aspects and Development of Transcatheter Aortic Valve Implantation
Journal of Cardiovascular Development and Disease
aortic stenosis
TAVI
materials
technology
title Technical Aspects and Development of Transcatheter Aortic Valve Implantation
title_full Technical Aspects and Development of Transcatheter Aortic Valve Implantation
title_fullStr Technical Aspects and Development of Transcatheter Aortic Valve Implantation
title_full_unstemmed Technical Aspects and Development of Transcatheter Aortic Valve Implantation
title_short Technical Aspects and Development of Transcatheter Aortic Valve Implantation
title_sort technical aspects and development of transcatheter aortic valve implantation
topic aortic stenosis
TAVI
materials
technology
url https://www.mdpi.com/2308-3425/9/8/282
work_keys_str_mv AT klemensteblovnik technicalaspectsanddevelopmentoftranscatheteraorticvalveimplantation
AT matjazbunc technicalaspectsanddevelopmentoftranscatheteraorticvalveimplantation